These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 27106834)

  • 61. Chronic stable angina pectoris.
    Jawad E; Arora R
    Dis Mon; 2008 Sep; 54(9):671-89. PubMed ID: 18725007
    [No Abstract]   [Full Text] [Related]  

  • 62. Metabolic modulation with perhexiline in chronic heart failure: a randomized, controlled trial of short-term use of a novel treatment.
    Lee L; Campbell R; Scheuermann-Freestone M; Taylor R; Gunaruwan P; Williams L; Ashrafian H; Horowitz J; Fraser AG; Clarke K; Frenneaux M
    Circulation; 2005 Nov; 112(21):3280-8. PubMed ID: 16301359
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Perhexiline maleate in the treatment of angina pectoris - double blind study].
    Cunha GP; Lopes M; Maranhão MF; Oliveira PF; Rojas RI
    Arq Bras Cardiol; 1975 Jun; 28(3):379-37. PubMed ID: 1101858
    [No Abstract]   [Full Text] [Related]  

  • 64. Proceedings: Clinical evaluation of perhexiline maleate in patients with angina pectoris associated with a positive coronary artery disease index.
    Cawein MJ; Lewis RE; Hudak WJ; Hoekenga MT
    Postgrad Med J; 1973 Apr; 49():Suppl 3:121-4. PubMed ID: 4587029
    [No Abstract]   [Full Text] [Related]  

  • 65. A multicentre trial of perhexiline maleate in the treatment of angina pectoris.
    Hitchcock PJ; Rutovitz IJ; Dando RV; Eathorne AJ; Weiss G
    Curr Ther Res Clin Exp; 1977 Jan; 21(1):36-42. PubMed ID: 401710
    [No Abstract]   [Full Text] [Related]  

  • 66. The Role of Ivabradine in the Management of Angina Pectoris.
    Giavarini A; de Silva R
    Cardiovasc Drugs Ther; 2016 Aug; 30(4):407-417. PubMed ID: 27475447
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Pexide, a new coronary drug].
    Garten J; Werhrschütz E
    Ther Ggw; 1975 Jun; 114(6):957. PubMed ID: 1096350
    [No Abstract]   [Full Text] [Related]  

  • 68. [A new anti-angina drug: Perhexiline maleate. Apropos of 50 cases].
    Raynaud P; Binet P; Henin JM; Raynaud R
    Therapeutique; 1973 Dec; 49(10):667-80. PubMed ID: 4600154
    [No Abstract]   [Full Text] [Related]  

  • 69. [The effect of antianginal preparations on the hemodynamics and metabolism of the ischemic myocardium].
    Makolkin VI; Vakhliaev VD
    Eksp Klin Farmakol; 1996; 59(4):18-20. PubMed ID: 9026181
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Perhexilene maleate--a new drug for the treatment of angina pectoris].
    Shalev O; Bassan M
    Harefuah; 1978 Aug; 95(3-4):134-5. PubMed ID: 700503
    [No Abstract]   [Full Text] [Related]  

  • 71. Metabolic support for the heart: complementary therapy for heart failure?
    Heggermont WA; Papageorgiou AP; Heymans S; van Bilsen M
    Eur J Heart Fail; 2016 Dec; 18(12):1420-1429. PubMed ID: 27813339
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Use of perhexiline maleate in angina pectoris therapy].
    Scébat L; Gay J; Gerbaux A
    Ann Cardiol Angeiol (Paris); 1973; 22(3):247-50. PubMed ID: 4731544
    [No Abstract]   [Full Text] [Related]  

  • 73. Effect of the anti-anginal agent, perhexiline, on neutrophil, valvular and vascular superoxide formation.
    Kennedy JA; Beck-Oldach K; McFadden-Lewis K; Murphy GA; Wong YW; Zhang Y; Horowitz JD
    Eur J Pharmacol; 2006 Feb; 531(1-3):13-9. PubMed ID: 16413015
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Perhexiline maleate in the management of patients with angina pectoris. A long-term assessment.
    Gitlin N
    S Afr Med J; 1974 May; 48(21):904-6. PubMed ID: 4600343
    [No Abstract]   [Full Text] [Related]  

  • 75. Treadmill exercise-tolerance test behavior in anginal patients treated with perhexiline maleate.
    Alcocer L; Aspe J; Arce-Gomez E
    Curr Ther Res Clin Exp; 1974 Mar; 16(3):163-70. PubMed ID: 4206724
    [No Abstract]   [Full Text] [Related]  

  • 76. Experimental and early investigational drugs for angina pectoris.
    Elgendy IY; Winchester DE; Pepine CJ
    Expert Opin Investig Drugs; 2016 Dec; 25(12):1413-1421. PubMed ID: 27791405
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Modification of myocardial substrate use as a therapy for heart failure.
    Abozguia K; Clarke K; Lee L; Frenneaux M
    Nat Clin Pract Cardiovasc Med; 2006 Sep; 3(9):490-8. PubMed ID: 16932766
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effects of various antianginal drugs on sodium influx in rat brain synaptosomes and in rat heart muscle cells in culture.
    Grima M; Freyss-Beguin M; Millanvoye-Van Brussel E; Decker N; Schwartz J
    Eur J Pharmacol; 1987 Jun; 138(1):1-8. PubMed ID: 3622602
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Targeting myocardial metabolism for the treatment of stable angina.
    Tousoulis D; Bakogiannis C; Briasoulis A; Papageorgiou N; Androulakis E; Siasos G; Latsios G; Kampoli AM; Charakida M; Toutouzas K; Stefanadis C
    Curr Pharm Des; 2013; 19(9):1587-92. PubMed ID: 23016716
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Relationship between plasma perhexiline concentration and symptomatic status during short-term perhexiline therapy.
    Stewart S; Voss DW; Northey DL; Horowitz JD
    Ther Drug Monit; 1996 Dec; 18(6):635-9. PubMed ID: 8946658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.